• 19908 Citations
  • 73 h-Index
1982 …2021
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Allan Struthers graduated MB (Hons) from Glasgow University UK in 1977. After junior hospital posts in Glasgow, he was Senior Registrar at the Royal Postgraduate Medical School and Hammersmith Hospital in London in 1982 – 1985.

He was then appointed Wellcome Senior Lecturer/Consultant Physician in Dundee and is currently Professor of Cardiovascular Medicine and runs the Heart Failure service at Ninewells Hospital in Dundee. He is also an Honorary Professor at St Andrews University Medical School. He was Chairman of the SIGN Guidelines in Heart Failure twice (2007 and 2016) and Chairman of NHS-QIS Standards (2010) for Heart Failure. In addition, he is also Chairman of Tenovus NSAC, Senior Regional Advisor for SACDA and a Council member of Chest, Heart and Stroke (Scotland).

He is currently Co-Head of the Division of Molecular and Clinical Medicine at the University of Dundee. Professor Struthers runs a large clinical research programme and has supervised 50 MD/PhDs.

He helped pioneer the use of plasma BNP to identify heart failure patients and the use of aldosterone blockers to reduce their mortality. 

Another research interest is in allopurinol and he has recently shown it to have antianginal oxygen sparing effects and to regress LV hypertrophy. He is currently funded (as PI) by the BHF, MRC, CSO, Diabetes (UK) and Chest, Heart & Stroke.  

In total he has held 38 different British Heart Foundation (BHF) grants. He has published 508 papers which are cited around 600 times every year. His research “h” factor is high at 60. He is a Fellow of the European Society of Cardiology (FESC), the Royal Society of Edinburgh (FRSE) and the Academy of Medical Sciences (FMed Sci). 

He teaches Cardiovascular Medicine and Therapeutics at both the University of Dundee and the University of St Andrews Medical School.

He has given 207 invited lectures, half abroad.

 

Research

Professor Struthers has repeatedly spotted new therapeutic opportunities and conducted the initial “proof of concept” studies which, led to confirmation in larger trials. For example, he was the first to ever show that aldosterone blockade had beneficial cardiac effects in man on top of ACE inhibitors (Am J Card 1995, 76: 1259): those effects were to reduce both ventricular arrhythmias and cardiac sympathetic activity. The discovery helped lead to the RALES trial where spironolactone reduced mortality in heart failure (HF) by 30%. He also discovered other mechanisms contributing to aldosterone’s ability to increase cardiac deaths, i.e. it decreases endothelial nitric oxide, it decreases cardiac autonomic function and it increases plasma collagen markers (which are a good surrogate for myocardial fibrosis).

A second area where he made important original discoveries is B-type natriuretic peptide (BNP). He wrote one of the two original studies published together in the Lancet (1993) which led to the use of plasma BNP levels to identify heart failure (HF). A later paper by him, also in the Lancet, confirmed this. BNP is now an integral part of all HF guidelines. Professor Struthers has now moved on to make original observations about BNP in a completely new (non HF) area. He has recently discovered that if an apparently healthy individual has a high BNP level, this often signifies that they have silent coronary artery disease (Heart 2006, 92: 487 and 916). This is a major finding as BNP screening could now be used to help identify those many apparently healthy middle aged individuals whose first ever manifestation of their previously silent coronary disease is sudden cardiac death.

A whole other area pioneered by him is allopurinol. He developed the novel idea that allopurinol could be “oxygen in a pill” because it inhibits an oxidase enzyme which normally “wastes” oxygen in ischaemic tissue. A recent Lancet paper (2010, 375: 2161 – 7) showing this could lead eventually to the use of allopurinol as an oxygen sparing agent in all ischaemic diseases. He had already unravelled the exact mechanism whereby allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not at all by decreasing uric acid. This was a much debated issue before his elegant paper in Circulation settled the issue.

Lastly, he had the original idea behind another paper of major therapeutic importance. In conjunction with Professor McMurdo, he showed that ACE inhibitors improve mobility in elderly, disabled, immobile patients, which should greatly improve the quality of life of many elderly patients. In fact, this paper won the Bruce P Squires award as one of the best in the year. If confirmed, ACE inhibitors could become the equivalent of “exercise in a pill” to the many elderly with limited mobility.

Teaching

He teaches Cardiovascular Medicine and Therapeutics at both the University of Dundee and the University of St Andrews Medical School.

Education/Academic qualification

Bachelor of Medicine and Bachelor of Surgery, University of Glasgow

Bachelor of Science, University of Glasgow

Keywords

  • RM Therapeutics. Pharmacology
  • Cardiovascular

Fingerprint Dive into the research topics where Allan Struthers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Heart Failure Medicine & Life Sciences
Atrial Natriuretic Factor Medicine & Life Sciences
Aldosterone Medicine & Life Sciences
Brain Natriuretic Peptide Medicine & Life Sciences
Angiotensin II Medicine & Life Sciences
Angiotensin-Converting Enzyme Inhibitors Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2021

Research Output 1982 2019

34 Downloads (Pure)

Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension

Gingles, C., Symon, R., Gandy, S., Struthers, A., Houston, G., MacDonald, T., Lang, C., Donnan, P. & George, J., 1 Jul 2019, In : Journal of Hypertension. 9 p.

Research output: Contribution to journalArticle

Open Access
File
Allopurinol
Hypertension
Placebos
Oxidative Stress
Left Ventricular Hypertrophy
31 Downloads (Pure)

A Randomized Controlled Trial of Metformin on Left Ventricular Hypertrophy in Patients with Coronary Artery Disease without Diabetes: The MET-REMODEL Trial

Mohan, M., Al-Talabany, S., McKinnie, A., Mordi, I., Singh, J., Gandy, S., Baig, F., Hussain, M. S. ., Bhalraam, U., Khan, F., Choy, A., Matthew, S., Houston, G., Struthers, A., George, J. & Lang, C. C., 17 Apr 2019, In : European Heart Journal. 9 p.

Research output: Contribution to journalArticle

Open Access
File
Metformin
Left Ventricular Hypertrophy
Coronary Artery Disease
Randomized Controlled Trials
Insulin Resistance
74 Downloads (Pure)

Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patients

Beveridge, L. A., Price, R. J. G., Burton, L. A., Witham, M. D., Struthers, A. D. & Sumukadas, D., 15 Jun 2018, In : BMC Research Notes. 11, 1, 5 p., 394.

Research output: Contribution to journalArticle

Open Access
File
Femoral Nerve
Visual Analog Scale
Muscle
Sarcopenia
Hand Strength
4 Citations (Scopus)
56 Downloads (Pure)

Development and Validation of a Path Length Calculation for Carotid-Femoral Pulse Wave Velocity Measurement: A TASCFORCE, SUMMIT, and Caerphilly Collaborative Venture

Weir-McCall, J., Brown, L. K., Summersgill, J., Talarczyk, P., Bonnici-Mallia, M., Chin, S. C., Khan, F., Struthers, A., Sullivan, F., Colhoun, H. M., Shore, A. C., Aizawa, K., Groop, L. C., Nilsson, J., Cockcroft, J. R., McEniery, C. M., Wilkinson, I. B., Ben-Shlomo, Y. & Houston, J. G., May 2018, In : Hypertension. 71, 5, p. 937-945 9 p.

Research output: Contribution to journalArticle

Open Access
File
Pulse Wave Analysis
Thigh
Angiography
Magnetic Resonance Spectroscopy
Confidence Intervals
1 Citation (Scopus)
59 Downloads (Pure)

Disconnection of pulmonary and systemic arterial stiffness in COPD

Weir-McCall, J. R., Liu-Shiu-Cheong, P. S., Struthers, A. D., Lipworth, B. J. & Houston, J. G., 28 May 2018, In : International Journal of Chronic Obstructive Pulmonary Disease. 13, p. 1755-1765 11 p.

Research output: Contribution to journalArticle

Open Access
File
Vascular Stiffness
Chronic Obstructive Pulmonary Disease
Pulse Wave Analysis
Healthy Volunteers
Lung

Prizes

Fellow of the Academy of Medical Science (FMedSci)

Allan D. Struthers (Recipient), 2011

Prize: National/international honour

Fellow of the Royal Society of Edinburgh (FRSE)

Allan D. Struthers (Recipient), 2010

Prize: National/international honour

SKB Prize

Allan D. Struthers (Recipient), 1992

Prize: Prize (including medals and awards)

Activities 2005 2009

  • 2 Participation in conference

British Geriatrics Society Spring Meeting

Allan D. Struthers (Participant)
2 Apr 2009

Activity: Participating in or organising an event typesParticipation in conference

19th Annual Conference of the European Health Psychology Society. Enhancing Individual, Family & Community Health

Allan D. Struthers (Participant)
2 Sep 2005

Activity: Participating in or organising an event typesParticipation in conference

Press / Media

High Dose Allopurinol Reduces Left Ventricular Mass In Patients With Ischemic heart Disease

Sushma Rekhraj, Stephen J. Gandy, Benjamin Szwejkowski, Adnan Nadir, Awsan Noman, J. Graeme Houston, Chim C. Lang, Jacob George & Allan D. Struthers

5/03/13

1 item of Media coverage

Press/Media: Research

Blood tests pick up early 'silent' heart disease

Adnan Nadir, Sushma Rekhraj, Li Wei, Tiong Lim, John Davidson, Thomas M MacDonald, Chim C. Lang, Eleanor Dow & Allan D. Struthers

24/09/12

1 item of Media coverage

Press/Media: Research

Thesis

A Comprehensive Analysis of SGLT2-inhibition in Type 2 Diabetes and Heart Failure

Author: Singh, J., 2019

Supervisor: Lang, C. (Supervisor) & Struthers, A. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

Allopurinol as a possible oxygen sparing agent during exercise in peripheral arterial disease

Author: Robertson, A., 2014

Supervisor: Struthers, A. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

File

Allopurinol Regresses Left Ventricular Hypertrophy in Patients with Type 2 Diabetes.

Author: Szwejkowski, B., 2014

Supervisor: George, J. (Supervisor) & Struthers, A. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

File

Effects of xanthine oxidase inhibitors in pulmonary hypertension associated with chronic lung disease

Author: Liu Shiu Cheong, P., 2019

Supervisor: Struthers, A. (Supervisor) & Lipworth, B. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

Prevalence of left ventricular hypertrophy in peripheral arterial disease and its relation to blood pressure

Author: Wright, G. A., 2014

Supervisor: Struthers, A. (Supervisor)

Student thesis: Doctoral ThesisDoctor of Medicine

File